The Gemcitabine Hydrochloride Market size is expected to reach US$ 1,297.83 million by 2034, up from US$ 873.1 million in 2025. The market is estimated to record a CAGR of 5.08% from 2026 to 2034. Market growth is being supported by the continued use of gemcitabine hydrochloride in cancer treatment, rising global cancer incidence, increasing demand for chemotherapy...